“Love Hormone” Oxytocin Could Be Used to Treat Cognitive Disorders Like Alzheimer’s
Scientists discover for the first time that oxytocin could be a potential new therapeutic option for cognitive disorders such as Alzheimer’s disease
Alzheimer’s disease progressively degrades a person’s memory and cognitive abilities, often resulting in dementia. Amid efforts to find novel treatments for this disease, a recent breakthrough study by scientists from Japan shows that oxytocin?the hormone that we commonly know to induce feelings of love and well-being?can also effectively reverse some of the damage caused by amyloid plaques in the learning and memory center of the brain in an animal model of Alzheimer’s.
Alzheimer’s disease is a progressive disorder in which the nerve cells (neurons) in a person’s brain and the connections among them degenerate slowly, causing severe memory loss, intellectual deficiencies, and deterioration in motor skills and communication. One of the main causes of Alzheimer’s is the accumulation of a protein called amyloid ? (A?) in clusters around neurons in the brain, which hampers their activity and triggers their degeneration. Studies in animal models have found that increasing the aggregation of A? in the hippocampus?the brain’s main learning and memory center?causes a decline in the signal transmission potential of the neurons therein. This degeneration affects a specific trait of the neurons, called “synaptic plasticity,” which is the ability of synapses (the site of signal exchange between neurons) to adapt to an increase or decrease in signaling activity over time. Synaptic plasticity is crucial to the development of learning and cognitive functions in the hippocampus. Thus, A? and its role in causing cognitive memory and deficits have been the focus of most research aimed at finding treatments for Alzheimer’s.
Now, advancing this research effort, a team of scientists from Japan, led by Professor Akiyoshi Saitoh from the Tokyo University of Science, has looked at oxytocin, a hormone conventionally known for its role in the female reproductive system and in inducing the feelings of love and well-being. “Oxytocin was recently found to be involved in regulating learning and memory performance, but so far, no previous study deals with the effect of oxytocin on A?-induced cognitive impairment,” Prof Saitoh says. Realizing this, Prof Saitoh’s group set out to connect the dots.
Their findings are published in Biochemical and Biophysical Research Communication.
Prof Saitoh and team first perfused slices of the mouse hippocampus with A? to confirm that A? causes the signaling abilities of neurons in the slices to decline or?in other words?impairs their synaptic plasticity. Upon additional perfusion with oxytocin, however, the signaling abilities increased, suggesting that oxytocin can reverse the impairment of synaptic plasticity that A? causes.
To find out how oxytocin achieves this, they conducted a further series of experiments. In a normal brain, oxytocin acts by binding with special structures in the membranes of brain cells, called oxytocin receptors. The scientists artificially “blocked” these receptors in the mouse hippocampus slices to see if oxytocin could reverse A??induced impairment of synaptic plasticity without binding to these receptors. Expectedly, when the receptors were blocked, oxytocin could not reverse the effect of A?, which shows that these receptors are essential for oxytocin to act.
Oxytocin is known to facilitate certain cellular chemical activities that are important in strengthening neuronal signaling potential and formation of memories, such as influx of calcium ions. Previous studies have suspected that A? suppresses some of these chemical activities. When the scientists artificially blocked these chemical activities, they found that addition of oxytocin addition to the hippocampal slices did not reverse the damage to synaptic plasticity caused by A?. Additionally, they found that oxytocin itself does not have any effect on synaptic plasticity in the hippocampus, but it is somehow able to reverse the ill?effects of A?.
Prof Saitoh remarks, “This is the first study in the world that has shown that oxytocin can reverse A?-induced impairments in the mouse hippocampus.” This is only a first step and further research remains to be conducted in vivo in animal models and then humans before sufficient knowledge can be gathered to reposition oxytocin into a drug for Alzheimer’s. But, Prof Saitoh remains hopeful. He concludes, “At present, there are no sufficiently satisfactory drugs to treat dementia, and new therapies with novel mechanisms of action are desired. Our study puts forth the interesting possibility that oxytocin could be a novel therapeutic modality for the treatment of memory loss associated with cognitive disorders such as Alzheimer’s disease. We expect that our findings will open up a new pathway to the creation of new drugs for the treatment of dementia caused by Alzheimer’s disease.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Reproductive hormone may curb COVID-19 inflammation, prevent cytokine stormon October 6, 2020 at 6:35 am
Researchers have used "omics" data containing genetic profiles of drugs to identify the hormone oxytocin as a possible treatment for COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2).
- Neurological Correlates Allow Us to Predict Human Behavioron September 30, 2020 at 9:56 pm
A combination of factors, from oxytocin release as an indicator of emotional investment to cortisol and other hormones that correlate with attention, can forecast what people will do after an ...
- Breastfeeding hormones make mothers happieron September 30, 2020 at 5:01 am
Oxytocin is one of the most important hormones between a mother and her baby. Researchers at Kyoto University and Azabu University in Japan report in a new study that the levels of oxytocin ...
- Science shows watching cute animals is good for your healthon September 27, 2020 at 6:43 am
It's sort of like the bond between mother and child. Thank the love hormone oxytocin. It's associated with attachment, love and trust. All things we develop with our pets. And she points to ...
- Science shows watching cute animals is good for your healthon September 27, 2020 at 6:42 am
Take it from an animal behaviorist and adjunct lecturer at some of the top schools in the New York area, she says the top dogs of the science world are seeing concrete, quantitative and qualitative ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Therapeutic options for cognitive disorders
- Cognitive flexibility training manages responses to social conflicton September 30, 2020 at 2:36 pm
Scientists at the Walter Reed Army Institute for Research and Army Research Laboratory have developed a computer-based training to reduce anger, reactive aggression and hostile attribution bias—the ...
- During Covid, Eating Disorder Patients Turn to Appson September 29, 2020 at 4:00 am
Anorexia, bulimia, and binge eating patients are facing novel challenges as in-person care is on hold. Can tech tools fill in the treatment gaps?
- Serial biopharma founder seeks to transform an Alzheimer's drug into an autism therapyon September 28, 2020 at 8:59 am
For years, hundreds of thousands of Alzheimer’s or dementia patients like local entrepreneur Mark Tepper’s late mother have relied on a drug with a modest benefit. Tepper thinks his new company can ...
- Cognitive behavioral therapy for insomnia provides reliefon September 22, 2020 at 5:00 pm
The Flinders University researchers found not only that a program of targeted cognitive behavioral therapy for insomnia ... is also available via telehealth options around Australia.
- ECT for Bipolar Disorder: Across-the-Board Symptom Reliefon September 22, 2020 at 5:00 pm
Electroconvulsive therapy achieved response rates of more than 80% for all symptoms of bipolar disorder and remission rates of more than 60% for several features, results of a large study show.